Healthcare -
Biotechnology - NASDAQ - US
$ 2.46
-0.806 %
$ 85 M
Market Cap
-2.62
P/E
GNLX - CASH & EQUIVALENTS
Cash & Equivalents GNLX - Genelux Corporation
9.42 M
LAST VALUE
44.75%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR